Merck & Co Inc
(XPAR:MRK)
€
101.4
0 (0%)
Market Cap: 291.54 Bil
Enterprise Value: 317.78 Bil
PE Ratio: 21.63
PB Ratio: 6.78
GF Score: 88/100 - Q2 2024 Merck & Co Inc Earnings Call TranscriptJul 30, 2024Earnings
- Q1 2024 Merck & Co Inc Earnings Call TranscriptApr 25, 2024€101.4Earnings
- Merck & Co Inc at Barclays Global Healthcare Conference TranscriptMar 12, 2024
- Merck & Co Inc at Leerink Partners Global Biopharma Conference TranscriptMar 11, 2024
- Merck & Co Inc at TD Cowen Health Care Conference TranscriptMar 05, 2024
- Q4 2023 Merck & Co Inc Earnings Call TranscriptFeb 01, 2024€101.4Earnings
- Merck & Co Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Merck & Co Inc at Goldman Sachs Healthcare C-Suite Unscripted Conference TranscriptJan 04, 2024
- Merck & Co Inc at Evercore ISI HealthCONx Conference TranscriptNov 30, 2023
- Merck & Co Inc at Jefferies London Healthcare Conference TranscriptNov 16, 2023
- Merck & Co Inc at UBS BioPharma Conference TranscriptNov 08, 2023
- Q3 2023 Merck & Co Inc Earnings Call TranscriptOct 26, 2023€101.4Earnings
- Merck & Co Inc To Host ESMO Call (Virtual) TranscriptOct 22, 2023
- Merck & Co Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Merck & Co Inc at Citi BioPharma Conference TranscriptSep 06, 2023
- Q2 2023 Merck & Co Inc Earnings Call TranscriptAug 01, 2023€101.4Earnings
- Merck & Co Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Merck & Co Inc Investor Event at ASCO 2023 TranscriptJun 05, 2023
- Merck & Co Inc Annual Shareholders Meeting TranscriptMay 23, 2023
- Merck & Co Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 Merck & Co Inc Earnings Call TranscriptApr 27, 2023€104.6 (+1.95%)Earnings
- Merck & Co Inc Acquisition of Prometheus Biosciences- M&A Call TranscriptApr 17, 2023
- Merck & Co Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Merck & Co Inc Investor Event at ACC.23/WCC TranscriptMar 07, 2023
- Q4 2022 Merck & Co Inc Earnings Call TranscriptFeb 02, 2023€95 (-3.46%)Earnings
- Merck & Co Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Merck & Co Inc at Goldman Sachs CEOs Unscripted Conference TranscriptJan 05, 2023
- Merck & Co Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 01, 2022
- Q3 2022 Merck & Co Inc Earnings Call TranscriptOct 27, 2022€99.6 (+1.74%)Earnings
- Merck & Co Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q2 2022 Merck & Co Inc Earnings Call TranscriptJul 28, 2022€89.9 (-0.11%)Earnings
- Merck & Co Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 13, 2022
- Merck & Co Inc at ASCO Annual Meeting TranscriptJun 07, 2022
- Merck & Co Inc Annual Shareholders Meeting TranscriptMay 24, 2022
- Merck & Co Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Q1 2022 Merck & Co Inc Earnings Call TranscriptApr 28, 2022€83.8 (+4.10%)Earnings
- Merck & Co Inc Cardiovascular Event TranscriptApr 05, 2022
- Merck & Co Inc at Cowen Health Care Conference (Virtual) TranscriptMar 07, 2022
- Merck & Co Inc ESG Investor Event TranscriptFeb 23, 2022
- Merck & Co Inc at SVB Leerink Global Healthcare (Virtual) TranscriptFeb 17, 2022
- Merck & Co Inc at Guggenheim Partners Healthcare Talks Oncology Days (Virtual) TranscriptFeb 09, 2022
- Q4 2021 Merck & Co Inc Earnings Call TranscriptFeb 03, 2022€70.5 (-3.05%)Earnings
- Merck & Co Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Merck & Co Inc at Evercore ISI HealthCONx Virtual Conference TranscriptDec 01, 2021
- Q3 2021 Merck & Co Inc Earnings Call TranscriptOct 28, 2021€73.59 (+3.94%)Earnings
- Acceleron Pharma Inc Acquired by Merck & Co Inc Call TranscriptSep 30, 2021
- Merck & Co Inc Oncology Event at ESMO 2021 TranscriptSep 20, 2021
- Merck & Co Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Q2 2021 Merck & Co Inc Earnings Call TranscriptJul 29, 2021€64.8 (-2.13%)Earnings
- Merck & Co Inc at Guggenheim Biopharma's Next Decade Virtual Conference TranscriptJun 22, 2021
- Merck & Co Inc Oncology Event at ASCO TranscriptJun 07, 2021
- Merck & Co Inc at CECP CEO Investor Forum (Virtual) TranscriptJun 07, 2021
- Merck & Co Inc Annual Shareholders Meeting TranscriptMay 25, 2021
- Merck & Co Inc Investor Day (Virtual) TranscriptMay 03, 2021
- Q1 2021 Merck & Co Inc Earnings Call TranscriptApr 29, 2021€61.05 (-4.39%)Earnings
- Merck & Co to Discuss Broad HIV Development Program and Newly Announced Collaboration with Gilead Sciences Inc - Conference Call TranscriptMar 15, 2021
- Merck & Co Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 09, 2021
- Merck & Co Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 03, 2021
- Q4 2020 Merck & Co Inc Earnings Call TranscriptFeb 04, 2021€64.2 (-1.53%)Earnings
- Merck & Co Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Merck & Co Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 02, 2020
- Q3 2020 Merck & Co Inc Earnings Call TranscriptOct 27, 2020€67.6 (+0.90%)Earnings
- Merck & Co Inc Oncology Virtual IR Briefing -- ESMO 2020 TranscriptSep 22, 2020
- Merck & Co Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 17, 2020
- Merck & Co Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2020
- Seattle Genetics Inc Discussion of Oncology Collaborations with Merck & Co Inc - Conference Call TranscriptSep 14, 2020
- Merck & Co Inc at Citi BioPharma Conference (Virtual) TranscriptSep 10, 2020
- Q2 2020 Merck & Co Inc Earnings Call TranscriptJul 31, 2020€66.4 (+0.61%)Earnings
- Merck & Co Inc Oncology Event at ASCO 2020 TranscriptJun 02, 2020
- Merck & Co Inc Annual Shareholders Meeting TranscriptMay 26, 2020
- Merck & Co Inc at UBS Global Healthcare Conference (Virtual) TranscriptMay 18, 2020
- Merck & Co Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 12, 2020
- Q1 2020 Merck & Co Inc Earnings Call TranscriptApr 28, 2020€75.4 (-2.08%)Earnings
- Merck & Co Inc at Cowen HealthCare Conference TranscriptMar 03, 2020
- Q4 2019 Merck & Co Inc Earnings Call TranscriptFeb 05, 2020€77 (-3.75%)Earnings
- Merck & Co Inc at JPMorgan Healthcare Conference TranscriptJan 14, 2020
- Merck & Co Inc at Evercore HealthCONx Conference TranscriptDec 04, 2019
- Q3 2019 Merck & Co Inc Earnings Call TranscriptOct 29, 2019€76 (+2.43%)Earnings
- Merck & Co Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptOct 02, 2019
- Merck & Co Inc at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Q2 2019 Merck & Co Inc Earnings Call TranscriptJul 30, 2019€74 (-0.67%)Earnings
- Merck & Co Inc Investor Day TranscriptJun 20, 2019
- Merck & Co Inc Annual Shareholders Meeting TranscriptMay 28, 2019
- Q1 2019 Merck & Co Inc Earnings Call TranscriptApr 30, 2019€70 (+1.45%)Earnings
- Q4 2018 Merck & Co Inc Earnings Call TranscriptFeb 01, 2019€67 (+4.69%)Earnings
Merck & Co Inc at JPMorgan Healthcare Conference Transcript
Jan 14, 2020 / 12:30AM GMT
Release Date Price:
€81
(+1.00%)
Christopher Thomas Schott
JP Morgan Chase & Co, Research Division - Senior Analyst
Good afternoon, everybody. I'm Chris Schott from JPMorgan. I'm very pleased to be hosting Merck today. From the company, we have Ken Frazier, Chairman and CEO; as well as Roger Perlmutter, President of Merck Research Labs.
First of all, Happy New Year, and thanks for joining us.
Kenneth C. Frazier
Merck & Co., Inc. - Chairman, President & CEO
Happy New Year to you, Chris, and thanks for having us.
Christopher Thomas Schott
JP Morgan Chase & Co, Research Division - Senior Analyst
Yes, we're going to be doing a fireside chat format. And like prior years, we're not going to be doing a breakout afterwards, so we'll just do the chat and then break from there.
Questions & Answers
Christopher Thomas Schott
JP Morgan Chase & Co, Research Division - Senior Analyst
So maybe Ken to open up and just help us set the stage for the conversation. Can you talk a
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)